VAV3 and acute lymphoblastic leukemia: In accordance with this mechanism of action, IODVA1 significantly decreases the survival of genetically diverse PDX B-ALL cells in a VAV3-dependent manner (Supplementary Fig. S3 and Fig. 6B).